4-[3-(azepan-4-yl)-6-[[(2S)-pentan-2-yl]amino]pyrazolo[3,4-d]pyrimidin-1-yl]cyclohexan-1-ol
C22H36N6O — CID 153365724
Data last refreshed: (MolForge compound catalog, from PubChem)
About 4-[3-(azepan-4-yl)-6-[[(2S)-pentan-2-yl]amino]pyrazolo[3,4-d]pyrimidin-1-yl]cyclohexan-1-ol
4-[3-(azepan-4-yl)-6-[[(2S)-pentan-2-yl]amino]pyrazolo[3,4-d]pyrimidin-1-yl]cyclohexan-1-ol (PubChem CID 153365724) has the molecular formula C22H36N6O and a molecular weight of 400.57 g/mol. Its IUPAC name is 4-[3-(azepan-4-yl)-6-[[(2S)-pentan-2-yl]amino]pyrazolo[3,4-d]pyrimidin-1-yl]cyclohexan-1-ol.
Molecular Properties
| Compound Name | 4-[3-(azepan-4-yl)-6-[[(2S)-pentan-2-yl]amino]pyrazolo[3,4-d]pyrimidin-1-yl]cyclohexan-1-ol |
|---|---|
| PubChem CID | 153365724 |
| Molecular Formula | C22H36N6O |
| Molecular Weight | 400.57 g/mol |
| Exact Mass | 400.30 |
| IUPAC Name | 4-[3-(azepan-4-yl)-6-[[(2S)-pentan-2-yl]amino]pyrazolo[3,4-d]pyrimidin-1-yl]cyclohexan-1-ol |
| SMILES | CCC[C@H](C)Nc1ncc2c(C3CCCNCC3)nn(C3CCC(O)CC3)c2n1 |
| InChI | InChI=1S/C22H36N6O/c1-3-5-15(2)25-22-24-14-19-20(16-6-4-12-23-13-11-16)27-28(21(19)26-22)17-7-9-18(29)10-8-17/h14-18,23,29H,3-13H2,1-2H3,(H,24,25,26)/t15-,16?,17?,18?/m0/s1 |
| InChIKey | UZYNFFJLXKDPKG-QSBIPNOOSA-N |
| XLogP | 3.76 |
| TPSA | 87.89 Ų |
| H-Bond Donors | 3 |
| H-Bond Acceptors | 7 |
| Rotatable Bonds | 6 |
| Heavy Atoms | 29 |
| Complexity | — |
Lipinski Rule of Five
Passes Rule of Five
| Rule | Value |
|---|---|
| MW ≤ 500 | 400.57 |
| LogP ≤ 5 | 3.76 |
| H-Bond Donors ≤ 5 | 3 |
| H-Bond Acceptors ≤ 10 | 7 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 153365724 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.